Drug Side Effects
Search
TRANSDIFFERENTIATION OF NEOPLASM
TRANSDIFFERENTIATION OF NEOPLASM
was reported 58 times
These drug classes are most commonly taken by patients reporting TRANSDIFFERENTIATION OF NEOPLASM:
#
Drug
Count
0
Platinum-based Drug [EPC]
25
1
Nucleoside Metabolic Inhibitor [EPC]
11
2
Topoisomerase Inhibitor [EPC]
11
3
Alkylating Drug [EPC]
9
4
Microtubule Inhibitor [EPC]
9
5
Androgen Receptor Inhibitor [EPC]
3
6
Estrogen [EPC]
2
7
Kinase Inhibitor [EPC]
2
8
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
9
BCL-2 Inhibitor [EPC]
1
10
CD20-directed Cytolytic Antibody [EPC]
1
11
CD22-directed Immunoconjugate [EPC]
1
12
Corticosteroid [EPC]
1
13
Folate Analog Metabolic Inhibitor [EPC]
1
14
Leukocyte Growth Factor [EPC]
1
15
Programmed Death Ligand-1 Blocker [EPC]
1
16
Radiographic Contrast Agent [EPC]
1